WednesdaySep 11, 2019 2:56 pm

QualityStocksNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Sees Strong Revenue Growth During Q2 2019

Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, announced that it obtained $3.7 million in new contracts during the second quarter of 2019 (http://ibn.fm/HagGQ). An article discussing the company reads, “During the second quarter of 2019, Spectrum witnessed strong revenue growth. Its total revenues reached $19.7 million, marking an increase of 29% on a quarterly basis. Gross profit during the second quarter was $1.2 million, or 13.9% of revenues. . . . The company brought down general and administrative expenses for Q2 2019 to $1 million (a reduction of 38% on an…

Continue Reading

WednesdaySep 11, 2019 2:16 pm

QualityStocksNewsBreaks – Geyser Brands Inc.’s (TSX.V: GYSR) NanoFusion Technology Provides Competitive Edge

Geyser Brands (TSX.V: GYSR) has developed its proprietary NanoFusion advanced delivery-system technology using natural materials to improve the transportation and delivery of active ingredients. Geyser’s NanoFusion is currently the only natural nanoemulsion on the market featuring no solvents or inflammatory agents. A recent article discussing the company reads, “Apart from ensuring a high level of bioavailability, the NanoFusion technology also increases the shelf life of cannabis products. In addition, it makes it possible for consumers to rely on lower doses to obtain optimal therapeutic benefits from a product. . . . All of the products featured in Geyser’s diversified portfolio…

Continue Reading

TuesdaySep 10, 2019 3:14 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Highlighted in Comprehensive Research Report

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, was recently covered in a research report by Eight Capital. Per the report, Eight Capital issued a ‘Buy’ rating and a target price of $4.50 for WLLW, determined in part by Willow’s chosen method of cannabinoid production, biosynthesis, which holds the potential to disrupt the industry. The report also detailed upcoming catalysts for the company, including the potential formation of partnerships and agreements; quantitative milestones demonstrating increased throughput of the company’s proprietary yeast strains; planned uplisting to the Toronto Stock…

Continue Reading

FridaySep 06, 2019 3:24 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Positive Findings from Master Collaborative Research Agreement

Biotechnology company and global drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced the successful completion of its master collaborative research agreement with the National Research Council of Canada (“NRC”) focused on technical aspects of DehydraTECH(TM)’s drug-delivery processes (http://ibn.fm/R94q9). An article further discussing the company reads, “Lexaria also noted that the National Research Council of Canada study discovered the remarkable stability of DehydraTECH technology, even under highly acidic conditions. ‘Other formulation technologies by third parties that have not been tested for pH stability cannot be relied upon to deliver stable quantities of the API in question…

Continue Reading

FridaySep 06, 2019 2:47 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Ideally Positioned to Benefit During U.S.-China Tariff Trade War

Sugarmade (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, currently holds a strong position as American farmers pursue refuge from the low prices and decreased sales created by the ongoing U.S.-China trade war. An article discussing the company reads, “In the wake of the trade war between the United States and China, hemp has become a refuge for American farmers suffering from the resulting lower prices and sinking sales, as detailed in a recent CannabisNewsWire article (http://ibn.fm/BhGYA). The uncertain trade relationship between the two countries has created an especially strong market…

Continue Reading

FridaySep 06, 2019 2:42 pm

QualityStocksNewsBreaks – Sharing Services Inc. (SHRG) Adds Value to Management Team with New Appointments

Diversified holdings company Sharing Services Global Corporation (OTCQB: SHRG) recently added supplementary value to its management team with the appointments of Garrett McGrath as chief impact officer and Sylvia McGrath as chief experience officer for Elepreneurs (http://ibn.fm/cR4bT). An article further discussing the company reads, “‘Garrett and Sylvia are two of the most respected, admired, and effective leaders in the network-marketing industry today,’ Elepreneurs president Keith Halls stated in a news release. ‘They have always led an energetic and experienced network marketing team, and we are grateful to have them as part of the family.’ . . . Sharing Services CEO John…

Continue Reading

FridaySep 06, 2019 2:32 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Planning Nationwide Rollout of Pain-Management Device

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, plans to have its innovative pain-management device available in all 50 states by 2020. An article discussing the company reads, “Technological advancements in the field will also contribute to the market’s growth by enabling the development of more effective devices. There are multiple types of pain-management devices. The market is currently dominated by neurostimulation devices, which accounted for over 50% of the sector’s revenue generated in 2018. This segment is anticipated to maintain its industry dominance over the forecast period. . . . Recently, Endonovo announced the rollout…

Continue Reading

FridaySep 06, 2019 2:14 pm

QualityStocksNewsBreaks – Why Predictive Oncology Inc. (NASDAQ: POAI) Is ‘One to Watch’

Data and artificial intelligence-driven discovery services company Predictive Oncology (NASDAQ: POAI) provides predictive models of tumor drug response to improve patient outcome. A recent article discussing the company reads, “Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based road map for therapy. . . . In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that…

Continue Reading

FridaySep 06, 2019 2:00 pm

QualityStocksNewsBreaks – Trxade Group Inc. (TRXD) Empowering Small, Independent Pharmacies

Trxade Group (OTCQB: TRXD), an integrated pharmaceutical services company, is focused on supporting independent and community-based small pharmacies through its innovative, web-based purchasing platform. A recent article discussing the company reads, “New product offerings have been developed to address customer demand, offering increased data analytics capability and better inventory/cost management, as TRXD chairman and CEO Suren Ajjarapu detailed in a news release. . . . TRXD’s network of independent pharmacies is also growing rapidly. By the end of June 2019, the company had registered the addition of 390 new independent pharmacies to its platform. This number represents an increase of…

Continue Reading

FridaySep 06, 2019 1:37 pm

QualityStocksNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Enhances Portfolio with VVG Acquisition

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) recently acquired Vegas Valley Growers North (“VVG”), a Las Vegas, Nevada, state-licensed cultivation and manufacturing firm (http://ibn.fm/7jcbv). An article discussing the company reads, “The VVG acquisition includes a leased 1,700-square-foot production facility and five state licenses for cultivation and manufacturing of both medical and recreational cannabis. VVG is also building a 60,000-square-foot manufacturing facility and has plans for a second 80,000-square-foot facility. Distribution licenses for both medicinal and recreational cannabis products are being processed by state regulators. . . . Also included in the acquisition was VVG’s popular Nevada vape brand, Vegas M…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered